Andson Biotech

Empowering Mass Spec for Biotech and Beyond

Y CombinatorWinter 2022ActiveHealthcareGene TherapyHard TechBiotechHealthcare

What they do

Problem

Pharmaceutical companies struggle to quickly and accurately measure difficult-to-detect chemicals needed for drug development and manufacturing quality control.

Solution

Andson Biotech provides mass spectrometry-based technologies that enable fast, accurate, high-throughput chemical measurements for drug development and QC.

Who it's for

Pharmaceutical and biotech companies developing and manufacturing biologics and cell therapies.

Founders

Mason Chilmonczyk

Founder

Mason is the co-founder and CEO of Andson Biotech, an academic spinout based on Mason's research at the Georgia Institute of Technology. At Andson, Mason is driving the company's mission to develop novel methodologies for advanced biomanufacturing discovery and monitoring. Mason is formally trained as a mechanical engineer with a BS from the University of South Florida ('14) and an MS and PhD from Georgia Tech ('17, '20).